Found: 25
Select item for more details and to access through your institution.
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24537-3
- By:
- Publication type:
- Article
Blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 6, p. 757, doi. 10.1111/bjh.12666
- By:
- Publication type:
- Article
Generation and characterization of an inducible transgenic model for studying mouse esophageal biology.
- Published in:
- BMC Developmental Biology, 2012, v. 12, n. 1, p. 18, doi. 10.1186/1471-213X-12-18
- By:
- Publication type:
- Article
X chromosome choice occurs independently of asynchronous replication timing.
- Published in:
- Journal of Cell Biology, 2005, v. 168, n. 3, p. 365, doi. 10.1083/jcb.200405117
- By:
- Publication type:
- Article
The Probability to Initiate X Chromosome Inactivation Is Determined by the X to Autosomal Ratio and X Chromosome Specific Allelic Properties.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005616
- By:
- Publication type:
- Article
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1783, doi. 10.3390/cancers14071783
- By:
- Publication type:
- Article
Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 436, doi. 10.3390/cancers14020436
- By:
- Publication type:
- Article
Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 6, p. 1417, doi. 10.1002/1878-0261.13555
- By:
- Publication type:
- Article
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 14, p. 2719, doi. 10.1002/1878-0261.13267
- By:
- Publication type:
- Article
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 7, p. 959, doi. 10.1093/clinchem/hvab040
- By:
- Publication type:
- Article
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2022, v. 34, n. 4, p. 566, doi. 10.1093/icvts/ivab291
- By:
- Publication type:
- Article
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0293707
- By:
- Publication type:
- Article
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.
- Published in:
- British Journal of Cancer, 2018, v. 119, n. 5, p. 558, doi. 10.1038/s41416-018-0194-7
- By:
- Publication type:
- Article
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
- Published in:
- BMC Medical Genomics, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s12920-020-00814-w
- By:
- Publication type:
- Article
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 1, p. 1, doi. 10.1007/s11060-023-04261-2
- By:
- Publication type:
- Article
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1347, doi. 10.1002/onco.13580
- By:
- Publication type:
- Article
Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 290, doi. 10.1002/onco.13631
- By:
- Publication type:
- Article
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216864
- By:
- Publication type:
- Article
Formalin fixation for optimal concordance of programmed death‐ligand 1 immunostaining between cytologic and histologic specimens from patients with non–small cell lung cancer.
- Published in:
- Cancer Cytopathology, 2021, v. 129, n. 4, p. 304, doi. 10.1002/cncy.22383
- By:
- Publication type:
- Article
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 683, doi. 10.1002/cncr.35090
- By:
- Publication type:
- Article
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01521
- By:
- Publication type:
- Article
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2019.01521
- By:
- Publication type:
- Article